Skip to main content

Table 2 Paired analysis of tumor cells before and after NACT

From: Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

 

Tumor cells after NACT

 

Tumor cells before NACT

Negative

Positive

Total

Total

96

22 (19 %)

118

 DTC-negative

73

14

87

 DTC-positive

23

8

31 (26 %)

Total

82

10 (11 %)

92

 CTC-negative

58

9

67

 CTC-positive

24

1

25 (27 %)

Total

39

9 (19 %)

48

 slCTC-negative

18

1

19

 slCTc-positive

21

8

29 (60 %)

  1. CTC circulating tumor cell, DTC disseminated tumor cell, NACT neoadjuvant chemotherapy
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us